RxDoctor Payments Data

Jonathan Moss, MD

Otolaryngology · Matthews, NCNPI 1447307244

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 91.5% of the total across 68 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 22.5% — the pattern of someone who eats at a lot of different presentations.

$3,841in general payments, 2019–2025

Across 68 payments — averaging $56.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Optinose US, Inc.$864
  • Sanofi$758
  • Regeneron Healthcare Solutions, Inc.$438
  • Medtronic$353
  • Covidien LP$325
  • Acclarent, Inc$245
  • plus $857 from 13 others
$160,316in research payments, 2019–2025

Across 39 payments — averaging $4110.68 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Covidien LP$61K
  • GSK$55K
  • Optinose US, Inc.$31K
  • Otonomy, Inc.$9K
  • Smith+Nephew$6K

What the payments were for

  • Consulting fees$3258%
  • Food & beverage$3,51692%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,841 in reported general payments places this provider in the 85th percentile of 362 otolaryngology providers in North Carolina.

See all otolaryngology providers in North Carolina

Medicare billing

Part B allowed, 2024
$146,472
Medicare patients
647
Services billed
2,399

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide131$3,093
Fluocinolone Acetonide Oil47$1,741
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth12$1,396
Pilocarpine Hcl28$970
Azelastine Hcl22$959
Tranexamic Acid14$904
Fluticasone Propionate42$612
Doxycycline Hyclate48$611
Gabapentin72$547
Mometasone Furoate22$392
Triamcinolone Acetonide15$343
Prednisone104$284
Methylprednisolone43$260
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav26$222
Clindamycin Hcl20$201

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Matthews

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →